alexa
Reach Us +1-217-403-9671
Editor - George Perry | University of Texas at San Antonio | 1691
ISSN: 0975-0851

Journal of Bioequivalence & Bioavailability
Open Access

Like us on:

OMICS International organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
All submissions of the EM system will be redirected to Online Manuscript Submission System. Authors are requested to submit articles directly to Online Manuscript Submission System of respective journal.

George Perry

George Perry
Editor-in-chief
George Perry

Dean and Professor
College of Sciences
University of Texas at San Antonio
USA
Tel: 210-458-4450
Fax: 210-458-4445
University of Texas at San Antonio

Biography

George Perry is dean of the College of Sciences and professor of biology at The University of Texas at San Antonio. Perry is recognized in the field of Alzheimer′s disease research particularly for his work on oxidative stress. Perry received his bachelor′s of arts degree in zoology with high honors from University of California Santa Barbara. After graduation he headed to Scripps Institution of Oceanography and obtained his PhD in marine biology under David Epel in 1979. He then received a postdoctoral fellowship in the Department of Cell Biology in the laboratories of Drs. Bill Brinkley and Joseph Bryan at Baylor College of Medicine where he laid the foundation for his observations of abnormalities in cell structures.
In 1982 Perry joined the faculty of Case Western Reserve University where he currently holds an adjunct appointment. He is distinguished as one of the top Alzheimer′s disease researchers with over 800 publications one of the top 100 mostcited scientists in neuroscience and behavior and one of the top 25 scientists in free radical research. Perry has been cited over 24000 times and is recognized as an ISI highly cited researcher Perry is editor for numerous journals and is editor-in-chief for the Journal of Alzheimer′s Disease. He is a fellow of the American Association for the Advancement of Sciences and past president of the American Association of Neuropathologists. Most recently he has been named a Foreign Correspondent Member of the Spanish Royal Academy of Sciences. Perry′s research is primarily focused on how Alzheimer disease develops and the physiological consequences of the disease at a cellular level. He is currently working to determine the sequence of events leading to damage caused by and the source of increased oxygen radicals.

Research Interest

Alzheimer disease, Oxidative stress, Parkinson disease, Cytoskeleton Mitochondria Amyloidosis, Neuropathology, Cytochemistry.

Certificate

Certificate

Global Speakers in the subject

Global Experts in the subject

Publications

Management of Neuro Degenerative Diseases of Elderly Adults

Ferric Iron Brain Deposition as the Cause, Source and Originator of Chronic Neurodegenerative Diseases

George Perry
Editor Note: J Alzheimers Dis Parkinsonism 2016, 6:e134
DOI: 10.4172/2161-0460.1000e134

CSF Biomarkers: Low Amyloid-β 1-42 and BDNF and High IFN γ Differentiate Children Exposed to Mexico City High Air Pollution V Controls. Alzheimer's Disease Uncertainties

Lucijan Mohorovic, Anna Lavezzi, Sanja Stifter, George Perry, Djulija Malatestinic, Vladimir Micovic and Eris Materljan
Research Article: J Environ Anal Chem 2015, 2:169
DOI: 10.4172/2380-2391.1000169

Cyclin Dependent Kinase 11, Neuroinflammation and Alzheimer's Disease: A Review

Lilian Calderón-Garcidueñas, Chih-kai Chao, Charles Thompson, Joel Rodriguez-Diaz, Maricela Franco-Lira, Partha S. Mukherjee and George Perry
Research Article: J Alzheimers Dis Parkinsonism 2015, 4:189
DOI: 10.4172/2161-0460.1000189

Pharmaceutical Regulation: Crossroad of Opportunity as the Distinction between Food and Drugs Blurs

Vladan Bajic, Boban Stanojevic, Lada Zivkovic, Andrea Cabarkapa, George Perry, Thomas Arendt and Biljana Spremo-Potparevic
Review Article: J Clin Cell Immunol 2015, 6: 305
DOI: 10.4172/2155-9899.1000305

A New Age in Metabolism

Elizabeth A. Perry, Rudolph J. Castellani and George Perry
Editorial: Pharmaceut Reg Affairs 2012, 1:e117
DOI: 10.4172/2167-7689.1000e117
Elizabeth A Perry, Rudolph Castellani, Paula Moreira and George Perry
Editorial: Metabolomics 2012, 2:e118
DOI: 10.4172/2153-0769.1000e118
Top